Skin Vascular Neoplasm

subtype

Identifier: CI-CAN-00001526
Entity page: /cancer/skin-vascular-neoplasm ↗
Edges: 24

Neighbours: 11 drugs10 trials
Drawn: 21 of 21 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Skin Vascular Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived11 of 11
→ investigated in trials for	Nivolumabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Skin Vascular Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Pomalidomidesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants

Skin Vascular Neoplasm studied in …STUDIED_INderived10 of 13show all (up to 200)
→ studied in	NCT04577755Phase 2 · active not recruiting Pomalidomide Treatment in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04339738Phase 2 · active not recruiting Testing the Addition of Nivolumab to Chemotherapy in Treatment of Soft Tissue Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Angiosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03069378Phase 2 · active not recruiting A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma · condition mapped ALIAS · 13 trials mapped (4 active)	—	—	Skin Angiosarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02799485Phase 2 · completed sEphB4-HSA in Treating Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07539454Phase 2 · not yet recruiting Nirogacestat in Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03601806Phase 2 · completed Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus Infection · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05846724Phase 2 · withdrawn Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Classic Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00975819Phase 2 · completed Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 13 trials mapped (4 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03077451Phase 2 · completed Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma · condition mapped ONTOLOGY_EXACT · 13 trials mapped (4 active)	—	—	Skin Kaposi Sarcoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02110069Phase 2 · terminated A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors · condition mapped ALIAS · 13 trials mapped (4 active)	—	—	Tufted Hemangioma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains